Skip to main content

ERRATUM article

Front. Med., 24 March 2023
Sec. Intensive Care Medicine and Anesthesiology
Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1186498

Erratum: Use of carboxyhemoglobin as an early sign of oxygenator dysfunction in patients supported by extracorporeal membrane oxygenation

This article is an erratum on:

  1. Use of Carboxyhemoglobin as an Early Sign of Oxygenator Dysfunction in Patients Supported by Extracorporeal Membrane Oxygenation

    1. Read original article
\n Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Use of carboxyhemoglobin as an early sign of oxygenator dysfunction in patients supported by extracorporeal membrane oxygenation

by Cousin, V. L., Giraud, R., Assouline, B., Silva, I. N., and Bendjelid, K. (2022). Front. Med. 9:893642. doi: 10.3389/fmed.2022.893642

An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva.”

The original article has been updated.

Keywords: carboxyhemoglobin, ECMO, critical care, hemolysis, oxygenator clotting

Citation: Frontiers Production Office (2023) Erratum: Use of carboxyhemoglobin as an early sign of oxygenator dysfunction in patients supported by extracorporeal membrane oxygenation. Front. Med. 10:1186498. doi: 10.3389/fmed.2023.1186498

Received: 14 March 2023; Accepted: 14 March 2023;
Published: 24 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.